Why the James Hardie Industries plc share price is falling today

The James Hardie Industries plc (ASX:JHX) share price is under pressure today after it flagged rising production costs today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The James Hardie Industries plc (ASX: JHX) share price fell 4.5% today after the US homebuilder and building materials supplier revealed its financial results for the year ending March 31 2017.

Below is a summary of the results with comparisons to the prior corresponding year. All figures in U.S. dollars.

  • Net profit of $276.5 million, up 13%
  • Adjusted net profit of $248.6 million, up 2%
  • Net sales of $1,921 million, up 11%
  • A second half of FY 2017 dividend of 28 cents per security
  • Total full year dividends of 38 cents per security
  • Q4 FY 2017 net profit of $54.6 million, down 6%

This is another solid looking result from a business that is enjoying the tailwinds of resurgent U.S. housing markets, with some strong sales growth, not translating quite so well to the bottom line.

The group blamed the margin compression on higher manufacturing costs in the U.S. and increased investment in "marketing development programs". It is these higher costs that are probably dragging the share price down this afternoon.

Outlook

The company stated that it expects "modest market growth" in U.S. housing markets to continue with the Australian and New Zealand businesses also expected to trend broadly in line with the average growth in housing construction markets.

James Hardie shares have nearly tripled in value over the past 5 years thanks to the housing boom in the U.S. and Australia, but it's not the only one enjoying that tailwind. Others to consider with perhaps better long-term growth outlooks include DuluxGroup Limited (ASX: DLX) or Nick Scali Limited (ASX: NCK).

Motley Fool contributor Tom Richardson has no position in any stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »